Monashee Investment Management »

Terns Pharmaceuticals shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $454k 54k 8.34
2024-03-31 $2.0M 300k 6.56
2022-12-31 $1.2M 123k 10.18

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Arthur J. Gallagher & Co. (AJG)
Landbridge Company Cl A (LB)
Sable Offshore Corp Com Shs (SOC)
Boeing Company (BA)
Amer Sports Com Shs (AS)
Abacus Life Cl A (ABL)
Biodesix (BDSX)

View all positions for Monashee Investment Management

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Vivo Capital
BlackRock
Deep Track Capital
Schonfeld Strategic Advisors
Vanguard Group
Citadel Advisors
Morgan Stanley
Nuveen Asset Management
Candriam Luxembourg S.C.A.
Driehaus Capital Management
Millennium Management
Geode Capital Management
T. Rowe Price Associates

View all funds holding Terns Pharmaceuticals